INTENT TO SOLE SOURCE gPROMS Lyophilization Modeling Toolbox (or equal)

Special NoticeNo Set AsideActive

Key Takeaways

  • Set-aside for No Set Aside businesses
  • Work to be performed in Rockville, MD
  • Industry: Software Publishers

Contract Details

Notice ID
FDA75F40126Q00155
Opportunity Type
Special Notice
Sub-Agency
FOOD AND DRUG ADMINISTRATION
Office
FDA Office of Acquisitions and Grants Services
Posted Date
Friday, May 22, 2026
Response Deadline
Tuesday, June 2, 2026
PSC Code
DH10
Set-Aside
No Set Aside
Place of Performance
Rockville, MD, 20857
Status
Active

Description

The FDA / Center for Drug Evaluation and Research (CDER) / Office of Pharmaceutical Quality Research (OPQR) requires to obtain an advanced lyophilization process modeling and simulation platform to study emerging pharmaceutical manufacturing technologies. Please review the attached Intent to Sole Source FDA-75F40126Q00155 document for more information.

Why This Opportunity Matters

HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking responses for software publishers with a set-aside for No Set Aside businesses in Rockville, MD. This set-aside designation means eligible businesses face reduced competition from larger firms.